Drug Benefits Co. Valued At $1.1B In PE Deal Led By 3 Firms
Advent International will acquire a significant stake in RxBenefits as part of a recapitalization that values the Alabama-based pharmacy benefits services provider at roughly $1.1 billion, the companies said Tuesday, in...To view the full article, register now.
Already a subscriber? Click here to view full article